10.1111/acel.13506 33 FriedmanS
In addition to a reported focus on labeling in hypothalamic obesity, PL7737 was granted Orphan Drug Designation status by the U.S
GLP-12024518 2022GLP-120020233505002025600 58%GLP-1 GLP-1PD-(L)12024BMS6PD-(L)1495PD-(L)1520 GLP-1PD-(L)1GLP-1PD-(L)1K 2024OzempicRybelsusWegovy292.962023212.0138%K2024212.012023250.1118% 2MASH 25mg7.2mgIIIbSTEP UPSTEP UP T2D GLP-1 420224.83202353.392024164.66 III2024SURMOUNT-5 FDA 202410FDAFDA GLP-1CagriSemaorforglipron Copyright 2025 PHARMCUBE
Number and date of entry of the food additive in the BFSA register: 161600201/01.05.2016 Packing: 100 capsules 7,93 8,40 7,36 14,52 4,50 6,60 8,40 7,67 6,40 6,80 14,40 11,97 6,90 7,16 8,69 2,30 6,19 1,12 8,90 1,28
Cork, PhD, study co-author, physiologist, and senior lecturer in the School of Medicine at Anglia Ruskin University
PMID: 35123548